Atrium Therapeutics Inc (RNA)

CapEx to Revenue

12.82%

TTM · Retrieved:

RNA logo

RNA CapEx to Revenue

Current (TTM)12.82%
RNA TTM CapEx/Revenue (12.82% → 12.82%)
More history is needed to export this chart.

RNA capex to revenue history

Published TTM snapshot. The date records when this current TTM value was retrieved.

Atrium Therapeutics Inc CapEx to Revenue — Published TTM snapshot
RetrievedCapEx to Revenue
12.8224%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.